BIOAVAILABILITY, PHARMACOKINETICS AND EFFECTS OF GLIPIZIDE IN TYPE-2 DIABETICS

被引：60

作者：

WAHLINBOLL, E

ALMER, LO

MELANDER, A

机构：

[1] UNIV LUND,MALMO GEN HOSP,DEPT CLIN PHARMACOL,S-21401 MALMO,SWEDEN

[2] UNIV LUND,MALMO GEN HOSP,DEPT MED,S-21401 MALMO,SWEDEN

[3] DEPT COMMUNITY CARE SCI,DALBY,SWEDEN

来源：

CLINICAL PHARMACOKINETICS | 1982年 / 7卷 / 04期

关键词：

D O I：

10.2165/00003088-198207040-00006

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：363 / 372

页数：10

共 7 条

[1] COMPARISON OF PHARMACOKINETICS OF GLIPIZIDE AND GLIBENCLAMIDE IN MAN [J].

BALANT, L ;

FABRE, J ;

ZAHND, GR .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (01) :63-69

[2] GLIPIZIDE - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE [J].

BROGDEN, RN ;

HEEL, RC ;

PAKES, GE ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1979, 18 (05) :329-353

[3] INTERACTION OF GLIPIZIDE WITH HUMAN-SERUM ALBUMIN [J].

CROOKS, MJ ;

BROWN, KF .

BIOCHEMICAL PHARMACOLOGY, 1975, 24 (12) :298-299

[4] AN IMPROVED GLUCOSE-OXIDASE METHOD FOR DETERMINING BLOOD, CSF AND URINE GLUCOSE LEVELS [J].

MARKS, V .

CLINICA CHIMICA ACTA, 1959, 4 (03) :395-400

[5] POTENTIATION OF INSULIN-SECRETION TO NON-GLUCOSE STIMULI IN NORMAL MAN BY TOLBUTAMIDE [J].

PFEIFER, MA ;

HALTER, JB ;

GRAF, R ;

PORTE, D .

DIABETES, 1980, 29 (05) :335-340

[6]

WAGNER JG, 1975, FUNDAMENTALS CLIN PH

[7] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF GLIPIZIDE AND SOME OTHER SULFONYLUREA DRUGS IN SERUM [J].

WAHLINBOLL, E ;

MELANDER, A .

JOURNAL OF CHROMATOGRAPHY, 1979, 164 (04) :541-546

← 1 →